Article Excerpt: From smartphones to wearables, digital devices have become a key aspect of everyday life. These technologies can collect an array of data about a person, such as their fitness level and mood. Harnessing these devices in clinical trials to capture digital biomarkers has the potential to enable more adaptive, patient-centric trials…
Digital biomarkers can be used in tandem with traditional trial measures, such as self-reports or clinical interviews. This enables the collection of objective, continuous data reflecting participants’ real-world experiences, which complements standard trial endpoints. “This can result in a more precise assessment of how a treatment affects daily functioning and behavior,” Dr. Nick Jacobson, associate professor in biomedical data science, psychiatry and computer science at the Geisel School of Medicine at Dartmouth, told Technology Networks.
Full Article: https://tinyurl.com/4b5kbf58
Article Source: Technology Networks